KIMBERLY WARD: Open Payments
NPI 1801430228 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$42 in 2 payments from 2 companies in 2025. Trend: 2023 $41 · 2024 $74 · 2025 $42
Food & beverage: $42
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $26 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: HyperRAB, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
